Melanoma Clinical Trials in Nashville

Showing 261-280 of 286 trials

Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

NCT00003568

RATIONALE: Vaccines may make the body build an immune response that will kill tumor cells. Interleukin-2 may stimulate a person's white blood cells to kill melanoma cells. PURPOSE: Randomized phase II trial to study the effectiveness of vaccine therapy with interleukin-2 in treating patients with metastatic melanoma.

Melanoma (Skin)

University of Illinois at ChicagoStarted Nov 1998

Duarte, California, United States • Chicago, Illinois, United States • Maywood, Illinois, United States +6 more locations

COMPLETEDPhase 2< 1 mile

Study of CP-675,206 in Refractory Melanoma

NCT00254579

CP-675,206 is a fully human monoclonal antibody (mAb). It binds to the CTLA4 molecule, which is expressed on the surface of activated T lymphocytes. CP-675,206 is thought to stimulate patients' immune systems to attack their tumors. CP-675,206 is not expected to have a direct effect on tumor cells. CP-675,206 been shown to induce durable tumor responses in patients with metastatic melanoma in Phase 1 and Phase 2 clinical studies.

Refractory Melanoma

AstraZeneca251 participantsStarted Dec 2005

Scottsdale, Arizona, United States • Bentonville, Arkansas, United States • Fayetteville, Arkansas, United States +62 more locations

Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

Study of CP-675,206 in Refractory Melanoma

Melanoma Trials in Other Cities

CP-675,206 In Patients With Advanced Melanoma

Study of XL281 in Adults With Solid Tumors

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.

Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma

A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma

Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma

A Study of Volociximab in Metastatic Melanoma

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma

In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis

Other Conditions in Nashville